首页 | 本学科首页   官方微博 | 高级检索  
     


Impact of ixekizumab treatment on skin‐related personal relationship difficulties in moderate‐to‐severe psoriasis patients: 12‐week results from two Phase 3 trials
Authors:L. Guenther  R.B. Warren  J.C. Cather  H. Sofen  Y. Poulin  M. Lebwohl  T. Terui  A. Potts Bleakman  B. Zhu  R. Burge  K. Reich  P. van de Kerkhof
Affiliation:1. Guenther Research Inc., London, Canada;2. The Dermatology Centre, Salford Royal Foundation Hospital, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK;3. Modern Research Associates, Dallas, TX, USA;4. Department of Medicine/Dermatology, UCLA School of Medicine, Los Angeles, CA, USA;5. Centre de Recherche Dermatologique du Québec Métropolitain, Quebec, Canada;6. Laval University, Quebec, Canada;7. Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA;8. Division of Dermatological Science, Department of Dermatology, Nihon University School of Medicine, Tokyo, Japan;9. Eli Lilly and Company, Indianapolis, IN, USA;10. Division of Pharmaceutical Sciences, Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH, USA;11. Dermatologikum Hamburg and SCIderm Research Institute, Hamburg, Germany;12. Department of Dermatology, Radboud University Nijmegen, Nijmegen, The Netherlands
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号